Dr. McDowell is a clinical fellow in Gynecology Oncology at the University of Kentucky Markey Cancer Center. He received his medical degree from Texas Tech University Health Sciences Center in Lubbock, TX and completed his residency in Obstetrics and Gynecology at Baylor Scott and White Health in Temple, TX. His research interests include ovarian cancer epidemiology and treatment.
Dr. McDowell's past research has been in developing and testing novel ovarian cancer treatments in both in vitro and in vivo testing models. Currently, he is in the Masters Program for Clinical Research Design at the University of Kentucky.
McDowell, A., Afroze, S.H., Tobin, R., McCormick, T.C., Newell-Rogers, M.K., Zawieja, D.C., Kuehl, T.J. and Uddin, M.N. (2016) Cinobufotalin as a Novel Agent to Inhibit in Vitro Epithelial Ovarian Cancer Cell Proliferation, Migration and Invasion. Open Journal of Obstetrics and Gynecology, 6, 343-351. http://dx.doi.org/10.4236/ojog.2016.66043
Dungrawala et al.: Identification of new cell size control genes in S. cerevisiae. Cell Division 2012 7:24.
Afroze S, Zawieja D, Tobin R, et al ID: 45: EVALUATION OF CELLULAR MECHANISMS BY WHICH CINOBUFOTALIN INHIBITS OVARIAN CANCER CELL LINES FUNCTION
Journal of Investigative Medicine 2016;64:950.